These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37168404)

  • 21. Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.
    Li XH; Sun CH; Mao R; Huang SY; Zhang ZW; Yang XF; Huang L; Lin JJ; Zhang J; Ben-Horin S; Feng ST; Chen MH; Li ZP
    Inflamm Bowel Dis; 2017 Feb; 23(2):244-253. PubMed ID: 28079618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development, Validation, and Evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index From the ImageKids Study.
    Focht G; Cytter-Kuint R; Greer MC; Pratt LT; Castro DA; Church PC; Walters TD; Hyams J; Navon D; Martin de Carpi J; Ruemmele F; Russell RK; Gavish M; Griffiths AM; Turner D
    Gastroenterology; 2022 Nov; 163(5):1306-1320. PubMed ID: 35872072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenteric lymph nodes in MR enterography: are they reliable followers of bowel in active Crohn's disease?
    Radmard AR; Eftekhar Vaghefi R; Montazeri SA; Naybandi Atashi S; Hashemi Taheri AP; Haghighi S; Salehnia A; Dadgostar M; Malekzadeh R
    Eur Radiol; 2018 Oct; 28(10):4429-4437. PubMed ID: 29696432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn's Disease.
    Kucharzik T; Wilkens R; D'Agostino MA; Maconi G; Le Bars M; Lahaye M; Bravatà I; Nazar M; Ni L; Ercole E; Allocca M; Machková N; de Voogd FAE; Palmela C; Vaughan R; Maaser C;
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):153-163.e12. PubMed ID: 35842121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance enterography for the evaluation of the deep small intestine in Crohn's disease.
    Ohtsuka K; Takenaka K; Kitazume Y; Fujii T; Matsuoka K; Kimura M; Nagaishi T; Watanabe M
    Intest Res; 2016 Apr; 14(2):120-6. PubMed ID: 27175112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography?
    Kim KJ; Lee Y; Park SH; Kang BK; Seo N; Yang SK; Ye BD; Park SH; Kim SY; Baek S; Ha HK
    Inflamm Bowel Dis; 2015 Jan; 21(1):101-9. PubMed ID: 25358063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.
    Eder P; Katulska K; Krela-Kaźmierczak I; Stawczyk-Eder K; Klimczak K; Szymczak A; Linke K; Łykowska-Szuber L
    Abdom Imaging; 2015 Oct; 40(7):2210-8. PubMed ID: 26048698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease.
    Rimola J; Fernàndez-Clotet A; Capozzi N; Rojas-Farreras S; Alfaro I; Rodríguez S; Masamunt MC; Ricart E; Ordás I; Panés J
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1563-1573. PubMed ID: 32886809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Findings of ulceration and severe stricture on MRE can predict prognosis of Crohn's disease in patients treated with anti-TNF treatment.
    Naganuma M; Okuda S; Hisamatsu T; Matsuoka K; Mori K; Hosoe N; Nakazato Y; Ogata H; Kanai T
    Abdom Radiol (NY); 2017 Jan; 42(1):141-151. PubMed ID: 27549100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of three magnetic resonance enterography indices for grading activity in Crohn's disease.
    Rimola J; Alvarez-Cofiño A; Pérez-Jeldres T; Ayuso C; Alfaro I; Rodríguez S; Ricart E; Ordás I; Panés J
    J Gastroenterol; 2017 May; 52(5):585-593. PubMed ID: 27599973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn's Disease?
    Foti PV; Travali M; Farina R; Palmucci S; Coronella M; Spatola C; Puzzo L; Garro R; Inserra G; Riguccio G; Zanoli L; Basile A
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803953
    [No Abstract]   [Full Text] [Related]  

  • 32. Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's disease.
    Kopylov U; Klang E; Yablecovitch D; Lahat A; Avidan B; Neuman S; Levhar N; Greener T; Rozendorn N; Beytelman A; Yanai H; Dotan I; Chowers Y; Weiss B; Ben-Horin S; Amitai MM; Eliakim R;
    Therap Adv Gastroenterol; 2016 Sep; 9(5):655-63. PubMed ID: 27582877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Risk of Surgery in Patients With Small Bowel Crohn's Disease Strictures Using Computed Tomography and Magnetic Resonance Enterography.
    Inoue A; Bartlett DJ; Shahraki N; Sheedy SP; Heiken JP; Voss BA; Fidler JL; Tootooni MS; Sir MY; Pasupathy K; Baker ME; Rieder F; Lightner AL; Deepak P; Bruining DH; Fletcher JG
    Inflamm Bowel Dis; 2022 Nov; 28(11):1677-1686. PubMed ID: 35032168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn's disease.
    Caruso A; Angriman I; Scarpa M; D'Incà R; Mescoli C; Rudatis M; Sturniolo GC; Schifano G; Lacognata C
    Abdom Radiol (NY); 2020 Aug; 45(8):2327-2335. PubMed ID: 31392397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohn's Disease.
    Fernandes SR; Rodrigues RV; Bernardo S; Cortez-Pinto J; Rosa I; da Silva JP; Gonçalves AR; Valente A; Baldaia C; Santos PM; Correia L; Venâncio J; Campos P; Pereira AD; Velosa J
    Inflamm Bowel Dis; 2017 Aug; 23(8):1403-1409. PubMed ID: 28498158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy.
    Messadeg L; Hordonneau C; Bouguen G; Goutorbe F; Reimund JM; Goutte M; Boucher AL; Scanzi J; Reymond M; Allimant C; Dapoigny M; Pereira B; Bommelaer G; Buisson A
    J Crohns Colitis; 2020 Nov; 14(11):1524-1534. PubMed ID: 32533769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent damage on magnetic resonance enterography in patients with Crohn's disease in endoscopic remission.
    Rimola J; Alfaro I; Fernández-Clotet A; Castro-Poceiro J; Vas D; Rodríguez S; Masamunt MC; Ordás I; Ricart E; Panés J
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1232-1241. PubMed ID: 30345577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn's disease: preliminary experience.
    Kovanlikaya A; Beneck D; Rose M; Renjen P; Dunning A; Solomon A; Sockolow R; Brill PW
    Abdom Imaging; 2015 Jun; 40(5):1068-74. PubMed ID: 25248794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the use of wireless capsule endoscopy with magnetic resonance enterography in children with inflammatory bowel disease.
    Hijaz NM; Attard TM; Colombo JM; Mardis NJ; Friesen CA
    World J Gastroenterol; 2019 Jul; 25(28):3808-3822. PubMed ID: 31391775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the gut layers in Crohn's disease: mucosal or transmural healing?
    Zacharopoulou E; Craviotto V; Fiorino G; Furfaro F; Zilli A; Gilardi D; Peyrin-Biroulet L; Danese S; Allocca M
    Expert Rev Gastroenterol Hepatol; 2020 Sep; 14(9):775-787. PubMed ID: 32515627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.